Who has invested in OncoVerity?

argenx, RefinedScience are named among the investors backing OncoVerity.

OncoVerity Funding: $72M Raised, Series A (2024)

OncoVerity funding overview

OncoVerity is based in Pittsburgh. OncoVerity has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2024. The round record for OncoVerity runs through 2024; nothing later has been disclosed. Investors on record include argenx, RefinedScience. 2 distinct backers are named across the disclosed rounds.

OncoVerity at a glance

Total raised: $72M
Latest round: Series A
Latest round date: November 2024
Headquarters: Pittsburgh
Notable investors: argenx, RefinedScience

Frequently asked about OncoVerity funding

How much has OncoVerity raised?: OncoVerity has raised $72M in total disclosed funding across the rounds on record.
Who has invested in OncoVerity?: argenx, RefinedScience are named among the investors backing OncoVerity.
What was the latest OncoVerity funding round?: The most recent disclosed round is a Series A, announced in November 2024.
Where is OncoVerity based?: OncoVerity is based in Pittsburgh.
When did OncoVerity last raise?: The last disclosed OncoVerity round closed in November 2024 at Series A.

Totals shown for OncoVerity aggregate every disclosed round on file. To see how that compares, browse the companies in Pittsburgh and the investors behind them below.

OncoVerity Funding: $72M Raised, Series A (2024)

OncoVerity funding overview

OncoVerity at a glance

Frequently asked about OncoVerity funding

Companies related to OncoVerity (18)

Browse related funding lists (3)